San Francisco, CA – On January 12, 2025, Biohaven and Yale Ventures partnered to host an exclusive pre-conference event at the J.P. Morgan Healthcare Conference, spotlighting the groundbreaking work of Yale University biotech spinouts. This event marked the third annual showcase collaboration between Biohaven and Yale Ventures at the premier healthcare investment industry gathering.

Held ahead of the highly anticipated 43rd Annual J.P. Morgan Healthcare Conference, the showcase brought together 200 investors and key figures from the life sciences and entrepreneurial communities from across the country. Attendees were treated to presentations from 9 Yale biotech spinouts, or startups formed to commercialize technology and research that originated at Yale University. Presenting companies included Biohaven, Arvinas, Bexorg, D2B3, Ensight-AI, Halda Therapeutics, Plythera, Stradefy Biosciences, and Rho Bio.

Josh Geballe, Managing Director of Yale Ventures, praised the partnership, saying:

“Many thanks to Vlad Coric, M.D., and our friends at Biohaven for partnering on a wonderful event last night highlighting Yale University biotech startups at the J.P. Morgan Healthcare Conference in San Francisco. Many of the 200 investors in attendance commented to me on the remarkable caliber of scientific innovation that was on display among the 9 Yale spinouts that presented.”

The showcase underscored New Haven’s growing reputation as a hub for life sciences innovation. The featured companies, which emerged from Yale University’s groundbreaking research ecosystem, represent a dynamic intersection of academic ingenuity and entrepreneurial drive.

“We are proud to partner with Yale Ventures on this year’s event to kick off JP Morgan,” said Vlad Coric, M.D., CEO of Biohaven. “The innovative work coming from our community demonstrates the value of collaboration between academia and the private sector to drive significant impact. By working together, we are creating transformative solutions to improve lives.”

The J.P. Morgan Healthcare Conference is the industry’s largest and most influential healthcare investment symposium, connecting global leaders, emerging companies, technology innovators, and investors. Events like Biohaven and Yale’s pre-conference gathering spotlight Yale and New Haven’s cutting-edge biotech research, highlighting their pivotal role in driving the life sciences industry in Connecticut.